Scientists Discover the Reasons Why statins Cause Muscle Pain

🩺 Brief Summary

A team of scientists has succeeded in uncovering the molecular reason behind why some people feel muscle pain when taking statin drugs (statins), the most famous medications used to lower cholesterol levels and prevent heart disease. Using cryo-electron microscopy, the interaction of statin molecules with ryanodine receptors (RyR1) in muscle cells was identified, leading to excessive calcium leakage. This mechanism explains the muscle damage associated with the drug, and this discovery has opened the door to developing a new generation of safer drugs that preserve their cholesterol-lowering benefits without affecting the muscles.

🧬 Statins: Vital Drugs Carrying Challenges

Statins are among the most important medical interventions in the field of cardiovascular disease prevention. By lowering cholesterol levels in the blood, these drugs play an effective role in reducing the likelihood of heart attacks and strokes. Despite their major successes, these drugs are not free of side effects that affect patients.

Some people suffer from muscle problems such as pain or weakness, and in rare cases severe muscle breakdown may occur that can even affect kidney function. These challenges have led to research aimed at understanding the precise reasons behind these symptoms.

🧪 Discovering the Molecular Mechanism of Muscle Damage

Scientists at the University of British Columbia and University of Wisconsin–Madison returned to the roots of the problem, using advanced cryo-electron microscopy. This technique makes it possible to study protein structures at near-atomic resolution inside muscle cells.

The research focused on ryanodine receptor 1 (RyR1), proteins that control the flow of calcium inside muscle cells and play a key role in triggering muscle contraction.

🔍 How do statins affect ryanodine receptors?

Ryanodine receptors act as a gate that allows calcium to exit when muscle contraction is needed, and this flow is precisely controlled to maintain tissue health. But the study revealed that statin molecules bind to these proteins in an abnormal way, causing the channel to remain open continuously and allowing chronic calcium leakage.

This continuous, uncontrolled flow leads to the activation of harmful processes inside muscle cells, causing pain and damage and, in severe cases, muscle breakdown that may threaten patients’ lives.

💡 Three statin molecules implicated in the damage

The researchers focused on atorvastatin (atorvastatin), one of the most widely used types of statin. They found that three molecules of the drug accumulate inside a specific cavity in the ryanodine receptor:

• The first molecule binds to the receptor when the channel is closed, increasing the likelihood that it will open.
• The other two molecules then enter and keep the channel open, leading to continuous calcium leakage.

This triple structure provides a clear explanation for how statins undesirably activate these muscle channels.

🧠 Future Goals for Developing Safe Drugs

With this precise molecular mechanism understood, the pharmaceutical industry can target modifications to the structure of statin molecules so that they do not interact with ryanodine receptors in muscles. This makes it possible to:

• Preserve the drug’s ability to lower cholesterol.
• Reduce painful muscle side effects.
• Increase patient adherence to treatment continuously without stopping due to pain.

This represents an important advance in designing drugs with high efficacy and better tolerability.

It is worth noting that more than 200 million people use statin drugs around the world, and although severe muscle injuries are rare, mild muscle complaints such as pain and fatigue are common and pose an obstacle for some patients.

🩻 Cryo-Electron Microscopy and Its Importance

The researchers in this study were able to rely on an advanced cryo-electron microscopy center within the Faculty of Medicine at the University of British Columbia, enabling them to image how statin molecules bind to ryanodine receptors in detail and at the atomic level.

This precise vision offered a clear explanation for a health problem affecting millions of users and confirmed the link between the drug’s molecular properties and its clinical effects.

🩺 Conclusion

The research was able to uncover the cause of statin-related muscle pain thanks to its analysis of the drug’s effect on ryanodine receptors that stimulate calcium flow inside muscles. This knowledge opens up prospects for developing safer cholesterol-lowering drugs that reduce muscle complications and preserve the benefits of heart protection. Although more studies and development are still needed before these findings can be applied, this step is considered a milestone in improving the quality of life of patients who depend on statins.

📚 Related articles

A 100-Year-Old Piano Mystery Is Solved in a New Scientific Discovery

2026/09/07

Experts Confirm That Blood Pressure Guidelines Overlook Half of the Health Equation

2026/09/08

🧬 Cannabis Compounds Relieve Chronic Pain Without Psychoactive Effects

2026/09/08